CJ Bioscience to Unveil Groundbreaking Data on Inflammatory Bowel Disease Treatment at ECCO 2025 At ECCO 2025, CJ Bioscience will share preclinical findings for CJRB-201, targeting inflammatory bowel disease, with clinical trials set for 2026.

CJ Bioscience to Unveil Groundbreaking Data on Inflammatory Bowel Disease Treatment at ECCO 2025 #South_Korea #Seoul #CJ_Bioscience #CJRB-201 #Inflammatory_Bowel